Elevated cholesterol is a significant risk factor for cardiovascular disease worldwide. Although there have been advancements in the management and treatment of high cholesterol, the implementation of these clinical care practices has not been consistent for patients, resulting in continued elevated cardiovascular risk for many. This panel will review the current quality landscape for cardiovascular disease risk reduction, with a focus upon cholesterol management. Through real-world case studies from across the healthcare system, panelists will discuss the challenges and successes of implementing effective cardiovascular risk reduction strategies. The panel will also examine ongoing changes and future directions in the quality landscape related to cardiovascular disease risk management.

Sponsored by: